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ABSTRACT
Complications after open heart surgery may threaten patient’s survival rate. The 
intraoperative methylprednisolone administration alone shows controversial results 
on open heart surgery complications. Similarly, the intraoperative and preoperative 
methylprednisolone administration as well as the use of hemofilter in open heart surgery 
is still controversial. This study aimed to evaluate the effect of hemofilter, preoperative 
and intraoperative methylprednisolone administration on complications following open 
heart surgery. This was a Prospective Randomized Open-Blinded Evaluation (PROBE) 
experimental study. Ninety-five patients who had open heart surgery in Dr. Sardjito 
General Hospital, Yogyakarta, and Integrated Cardiac Care of Dr. Cipto Mangunkusumo 
General Hospital, Jakarta within the period of December 2011 to May 2012 were 
involved in this study. The patients were divided into two groups i.e. group A, 48 patients 
received methylprednisolone 15mg/kg intraoperatively, methylprednisolone 5mg/kg 
preoperatively, and hemofilter,  while group B, 47 patients received methylprednisolone 
15mg/kg intraoperatively alone. From the total 95 patients, we found 26 (27.4%) 
patients experienced complications i.e. 19 in group B (40.4%) and 7 in group A 
(14.6%). The differences of the complications were statistically significant (p<0.05; 
OR=3.97; 95%CI=1.476-10.71). Complications risk decreased by 63.9% in the group 
A compared to the group B with the hazard ratio of 3.2. In conclusion, the application of 
hemofilter, preoperative and intraoperative methylprednisolone might decrease the risk of 
complications after open heart surgery. 
ABSTRAK
Komplikasi paska bedah jantung terbuka dapat mempengaruhi angka harapan hidup pasien. 
Pemberian intraoperatif metilpredinsolon saja untuk mencegah komplikasi paska bedah 
jantung terbuka masih menunjukkan hasil yang kontroversial. Pemberian metilprednisolon 
preoperatif dan intraoperatif serta penggunaan hemofilter masih kontroversial. Penelitian 
ini bertujuan untuk mempelajari efek hemofilter, pemberian preoperatif dan intraoperatif 
metilprednisolon terhadap komplikasi paska bedah jantung terbuka. Penelitian ini merupakan 
studi eksperimental dengan desain Prospective Randomized Open-Blinded Evaluation 
(PROBE). Didapatkan 95 pasien yang menjalani bedah jantung terbuka di Rumah Sakit 
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Umum Pusat Dr. Sardjito, Yogyakarta, dan Pusat Jantung Terpadu Rumah Sakit Umum 
Pusat Dr. Cipto Mangunkusumo, Jakarta, pada periode waktu Desember 2011 hingga Mei 
2012. Pasien dibagi menjadi 2 grup yaitu grup A (48 pasien) menerima metilprednisolon 
intraoperatif (15mg/kg), metilprednisolon praoperatif (5mg/kg), dan hemofilter (kelompok 
A) dan grup B (47 pasien) menerima metilprednisolon intraoperatif (15mg/kg) saja. Dari 
total 95 pasien, didapatkan 26 (27,4%) sampel mengalami komplikasi (27,4%) yang 
terdiri dari 19 pada kelompok B (40,4%) dan 7 pada kelompok B (14,6%). Perbedaan 
terjadinya komplikasi ini berbeda nyata (p < 0.05; OR= 3,97; 95%CI=1,476-10,71). 
Risiko komplikasi menurun 63,9% pada kelompok A dibandingkan dengan kelompok B 
dengan hazard ratio 3,2. Dapat disimpulkan bahwa penggunaan hemofilter, pemberian 
metilprednisolon preoperatif dan intraoperatif dapat menurunkan risiko komplikasi paska 
bedah jantung terbuka. 
Keywords: hemofilter – methylprednisolone – complication - open heart surgery – intraoperative
INTRODUCTION
The mortality rate related to open heart 
surgery has declined since the improvements 
of procedure, preoperative, and postoperative 
preparation. However, complications of 
open heart surgery are still threatening 
patient’s survival such as cardiac rhythm 
and contractile disturbance, electrolyte 
imbalance, renal, pulmonary, gastrointestinal, 
hematopoietic, and central nervous system 
function disturbance.1 
Cardiopulmonary bypass is a technique 
which been used in open heart surgery to take 
over the function of the heart and maintain the 
circulation of blood which distinguish heart 
surgery from other surgery. Unfortunately, 
some complications may follow this procedure, 
such as vasospasm, altered platelet-endothelial 
cell interactions, and systemic inflammatory 
response due to contact of blood and synthetic 
surface of bypass equipment. It may lead to 
declining level of microcirculation of heart, 
brain, and other organs, which may cause 
organ dysfunction.2 Complication is one of the 
leading cause of death in open heart surgery. 
It also may cause morbidity and increase the 
length of hospital stay.1 The use of hemofilter 
in cardiopulmonary bypass machine may 
reduces systemic fluid overload after cardiac 
surgery and prevents several complications.3
Corticosteroid prophylaxis in heart 
surgery has been studied for several years, 
however its role remains controversial.4-8 
Several mechanisms of corticosteroid’s benefit 
on patient who required cardiopulmonary 
bypass have been shown on prior studies. 
They may include reduction in the expression 
of endothelial molecule, improvement in 
myocardial and pulmonary cell integrity, 
cytokine release, and complement activation.9 
Corticosteroid may be an effective method 
to reduce open heart surgery complications 
related to the inflammatory response.4,6 
However, another study has reported 
that administration of intraoperative 
methylprednisolone prophylaxis only has not 
been shown to reduce surgical complications.10 
Therefore, in this study we wished to analyze 
the effect of preoperative and intraoperative 
methylprednisolone and application of 
hemofilter on complications after open heart 
surgery. 
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MATHERIALS AND METHODS
Design and subjects
We conducted an experimental study 
using Prospective Randomized Open-Blinded 
Evaluation (PROBE) design. This study 
took place at Dr. Sardjito General Hospital, 
Yogyakarta and Dr. Cipto Mangunkusumo 
General Hospital, Jakarta within the period of 
December 2011 until May 2012. The ethical 
clearance of this study has been approved 
by the Medical and Health Research Ethic 
Committee, Faculty of Medicine, Universitas 
Gadjah Mada/Dr. Sardjito General Hospital, 
Yogyakarta (Ref. KE/FK/768/EC) and Faculty 
of Medicine, Universitas Indonesia/Dr. Cipto 
Mangunkusumo General Hospital, Jakarta 
(Ref. 364/PT02.FK/ETIK/2012).
The subjects were above 18 years 
old and diagnosed with a heart defect, 
and underwent open-heart surgery at Dr. 
Sardjito General Hospital, Yogyakarta and 
integrated the Cardiac Center of Dr. Cipto 
Mangunkusumo General Hospital, Jakarta. 
The subjects were divided into two groups 
using block randomization i.e. Group A, 
the patients were treated with intraoperative 
methylprednisolone (15 mg/kg), preoperative 
methylprednisolone (5 mg/kg) and hemofilter 
and  Group B, the patients were treated with 
intraoperative methylprednisolone (15 mg/
kg) only. 
Experimental procedure
Complication was measured as morbidity 
such as myocardial infarction, lung function 
disturbances, kidney function disturbance, 
and postoperative infection which happened 
within 30 days post-surgery. Myocardial 
infarction (MI) was a necrosis of cardiac 
myocyte due to insufficient oxygen and 
blood perfusion and measured by ECG and 
Troponin I level. Pathologic Q wave and ST- 
segment elevation was measured as a sign of 
cardiac muscle necrosis. Troponin I marker 
was measured twice: before surgery and 3 
hours after surgical wound closure finished. 
Troponin I level was labeled as abnormal if the 
level was >0.1 ng/mL. ECG was monitored on 
Marquet invasive monitor during the surgical 
procedure and post-surgical care in ICU.
Pulmonary function disturbance was a 
decreasing in pulmonary function, measured 
by blood gas analysis and chest X-ray. Blood 
gas analysis was measured 4 times on 3, 24, 
48 and 72 hours post-surgery. Blood gas 
analysis was labeled as abnormal if Pa O2 < 80 
mmHg, Pa CO2 < 32 mmHg, or > 45 mmHg, 
pH < 7.35, or pH > 7.45. Chest X-ray was 
done in anteroposterior projection as much 
as 4 times on 3 and 24 hours post-surgery, 
on hospital discharge, and on follow up in 
clinic. Chest X-ray was labeled as abnormal 
if there was a sign of pulmonary edema, 
hemothorax, pneumothorax, pleural effusion, 
or pneumonia/ bronchopneumonia. Kidney 
function disturbance was a decreasing in 
kidney function measured as a decreasing in 
urine output below the level of 0.5 cc/kg/hour, 
or blood creatinine level ≥ 1.5 mg/dL. Any 
signs of infection within 30 days post-surgery 
on surgical wound, pericardium, or lung was 
noted as postoperative infection and recorded 
in a medical record. 
Statistical analysis
We compared the mean values of 
continuous variables using independent t-test 
or analysis of variance (Anova). Categorical 
variables were analyzed using Chi-square or 
Fisher exact test. Analysis of survival, free 
of complications and mortality figures was 
calculated using the Kaplan-Meier method 
and the log rank test curve. Comparison of 
survival, complication-free numbers and 
mortality rate between the two groups was 
performed with the log-rank test. 
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RESULTS
During the 6 months period, 96 patients 
were ascertained in this study. We found one 
incomplete data and excluded it from the study. 
Finally, 95 patients were analyzed consisted 
Variable [n (%)] Group A[48 (50.5)]
Group B
[47 (49.5)]
Total
[95 (100)] p
Age (Years)
> 30 39 (81.3) 41(87.2) 80 (84.2) 0.451
< 30 9 (18.7) 6 (12.8) 15 (15.8)
Sex
Male 26 (54.2) 22 (46.8) 48 (50.5) 0.473
Female 22 (45.8) 25 (53.2) 47(49.5)
NYHA class
Two 33 (68.8) 27 (57.4) 60 (63.2) 0.239
Three 15 (31.3) 18 (38.3) 33 (34.7)
Four 0 2 (4.3) 2 (2.1)
Hb 
Abnormal 3 (6.7) 1 (2.3) 4 (4.5) 0.617
Normal 42 (93.3) 42 (97.7) 84 (95.5)
Creatinine
Abnormal 19 (42.2) 15 (35.7) 34 (39.1) 0.534
Normal 26 (57.8) 27 (64.3) 53 (60.9)
Ureum
Abnormal 7 (16.3) 2 (4.7) 9 (10.5) 0.156
Normal 36 (83.7) 41 (95.3) 77 (89.5)
Albumin 
Abnormal 3 (6.7) 4 (9.5) 7 (8.0) 0.707
Normal 42 (93.3) 38 (90.5) 80 (92.0)
Random Glucose test
Abnormal 3 (6.8) 7 (16.7) 10 (11.6) 0.191
Normal 41 (93.2) 35 (83.3) 76 (88.4)
Kalium
Abnormal 4 (9.3) 2 (4.8) 6 (7.1) 0.676
Normal 39 (90.7) 40 (95.2) 79 (92.9)
Natrium 
Abnormal 5 (11.6) 2 (4.8) 7 (8.2) 0.433
Normal 38 (88.4) 40 (95.2) 78 (91.8)
Magnesium 
Abnormal 2 (4.9) 6 (16.7) 8 (10.4) 0.137
Normal 39 (95.1) 30 (83.3) 69 (89.6)
Calcium 
Abnormal 0 3 (8.3) 3 (4.0) 0.106
Normal 39 (100) 33 (91.7) 72(96.0)
of 48 patients of the group A, and 47 patients 
of the group B. The baseline characteristics 
between the group A and group B were not 
statistically different (p>0.05) as shown in 
TABLE 1.
TABLE 1. Subject baseline characteristic between treatment groups
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We found 26 (27.4%) complication 
incidence, among them 19 were the group 
B and 7 were group A. The most frequent 
complication was pleural effusion (38.5%) 
and pulmonary edema (34.6%). We found no 
significant correlation between each type of 
complication and treatment groups (p>0.05) 
as shown in TABLE 2.
TABLE 2. Distribution of complications following open heart surgery
Complication Group A(n=48)
Group B
(n=47)
Total
[n= 95 or 
100%]
p
Pulmonary edema 2 7 9 (34.6) 0.0744
Pleural effusion 3 7 10 (38.5) 0.1497
Stroke 1 0 1 (3.8) 0.5053
AV Block 1 1 2 (7.7) 0.7474
Wound infection 0 2 2 (7.7) 0.2421
Pneumonia 0 1 1 (3.8) 0.4947
Low cardiac out put 0 1 1 (3.8) 0.4947
Total 7 19 26 
We analyzed the incidence of postoperative 
complications between the group A and group 
B. Analysis using Chi-square showed that 
postoperative complication to group A was 
significantly lower compared to group B 
(p<0.05; OR = 3.97; 95% CI = 1.476 - 10.71), 
indicating that the group B may experience 
complications almost 4 times higher than 
compared to those in the group A (TABLE 3).
TABLE 3. Incidence of post-operative complications in group A and B
Group 
Complication
[n (%)] OR (95%CI) p
Yes No Total
A 19 (73.1) 28 (40.6) 47 (49.5) 3.97 (1.476-10.71) 0.005
B 7 (26.9) 41 (59.4) 48 (50.5) 1
 
The result of Kaplan-Meier analysis 
showed that incidence of complications of 
the group A compared to the group B was 
statistically different (p<0.004) and hazard 
ratio = 3.2, which meant the group B was 3.2 
times more likely to develop complications 
within 30 days compared to the group A 
(FIGURE 1).
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FIGURE 1.  Kaplan Meier graphic of the group A and B toward complication
Comparative analysis between both groups 
on the incidence of complications showed 
that treatment the group A’s complication risk 
decreased by 63.9% compared to the treatment 
group B (TABLE 4).
TABLE 4. Analysis of relative risk ratio (RRR) of complication event between groups
Groups
Complication [n (%)]
OR (95% CI) p
Yes No Total
Group A 7 (26.9) 41 (59.4) 48 (50.5) 0.25 (0.08-0.74) 0.005
Group B 19 (73.1) 28 (40.6) 47 (49.5) 1
 
 RRR=0.639 (0.223-0.833); ARR=0.258 (0.079-0.419); NNT=3 (13-2)     
DISCUSSION
This study showed that the incidence 
of complications was lower in the group A 
than the group B. Evidence suggests that the 
administration of prophylaxis corticosteroids 
is effective in reducing cardiac surgery 
complication, especially atrial fibrillation.4,11 
Furthermore, the administration of 
preoperative systemic steroid may give benefit 
in reducing postoperative ICU and hospital 
stay due to complication.12,13 Pleural effusion 
is the most frequently observed complication. 
Postoperative pleural effusions are commonly 
found in patients who undergo open heart 
surgery. About 10% of the patients who 
undergo cardiac surgery develop a pleural 
effusion.14
Cardiac surgery and cardiopulmonary 
bypass induce systemic acute inflammatory 
response and fluid overload, which may 
contributes to postoperative complications.3,4 
The administration of methylprednisolone 
may prevent complications related to this 
inflammatory response.4 Fluid overload can 
be removed using hemofilter.3 However, the 
administration of methylprednisolone alone 
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cannot overcome the fluid overload and 
the use of hemofilter alone is inadequate in 
reducing inflammatory response.15 
The group B was more likely to develop 
complications compared to the group 
A. Furthermore, risk of complications in 
the group A was significantly decreased. 
Decreased incidence of complications in 
this study is much higher compared to 
prior study.16 These results clearly support 
the use of combined methylprednisolone 
and hemofilter in cardiac surgery with 
cardiopulmonary bypass as the solution for 
preventing postoperative complications. 
Combination of methylprednisolone 
administration and hemofilter application 
can reduce both inflammatory response and 
fluid overload after cardiac surgery using 
cardiopulmonary bypass, which contribute to 
significant prevention of many postoperative 
complications.    
CONCLUSION
The combination of hemofilter application, 
preoperative and intraoperative administration 
of methylprednisolone might decrease the risk 
of complications after open heart surgery 
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